Sentences with phrase «medicine company»

A Chinese regenerative medicine company will provide financial support, according to the account.

SAN DIEGO, October 11, 2016 — ViaCyte, Inc., a privately - held regenerative medicine company with the first pluripotent stem cell - derived islet replacement therapy for the treatment of diabetes in clinical - stage development, today announced four presentations at upcoming healthcare events.

San Diego, California, October 29, 2013 — ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty foreign.

3DS is a personalized medicine company with a software platform based on the three - dimensional analysis of chromosomal signatures.

About ViaCyte ViaCyte is a privately - held regenerative medicine company developing novel cell replacement therapies as potential long - term diabetes treatments to reduce the risk of hypoglycemia and diabetes - related complications.

That's according to Peter Hames, co-founder and CEO of digital behavioral medicine company Big Health who created Sleepio, a digital sleep improvement program which has logged millions of users» sleep hours, undergone multiple clinical trials, and is based upon the proven effectiveness of cognitive behavioral therapy (CBT).

Perth - based regenerative medicine company Avita Medical says it will be able to focus more on its core ReCell technology after completing the sale of its respiratory business for $ 2.47 million.

What you get is your naturopath imposing his view of the world on you, a view that is likely to be unduly influenced by the marketing dollars of the big alternative medicine companies.

Just in time for allergy season, allergy medicine company Zyrtec has launched an Alexa skill that shares the daily pollen count for the user's location.

Just in time for allergy season, allergy medicine company Zyrtec has launched an Alexa skill that shares the daily pollen count for the user's location.

TORONTO, June 12, 2015 — MaRS EXCITE announced today that Assurex Canada, a precision medicine company that helps patients with mental health disorders, has joined its evaluation platform.

Since that deal began in 2015, the GSK Consumer Healthcare team has been closely involved in the legal and operational aspects of integrating two distinct legacy cultures together under a single business unit to form the leading over-the-counter medicines company in the world.

By partnering with Californian digital medicine company Proteus, the original pill will be enhanced with sensors that track whether a drug regimen is being adhered to.

«Personalized medicine companies [have been] trying to deal with this for going on 2 years and keep expressing a lot of frustration,» Sauer says.

«I think this is an extremely important — and solid — paper,» says stem cell researcher Robert Lanza, vice president of research and scientific development at Applied Cell Technology, a regenerative medicine company headquartered in Alameda, Calif., who did not take part in the study.

The two co-founded the lab's first spinoff laboratory in its 115 - year history in 2013, regenerative medicine company Novo Biosciences Inc..

The 2017 Annual Data Report details industry - specific statistics and trends from more than 850 leading cell therapy, gene therapy, tissue engineering, and other regenerative medicine companies worldwide.

For personalized medicine companies like Optimal Medicine Ltd., the patents are about protecting billions of dollars invested in years of research.

Natural Medicine companies, for the most part, won't pay to study natural medicines because no one can patent and make billions off of a well known and effective natural medicine such as garlic.

According to the pet medicine company, Banixx, this is a fairly common health problem with bulldogs, an elongated soft palate happens when the roof of your dog's mouth goes beyond the opening and goes into the larynx and the airways.

Set in a pair of 1895 buildings, which once included the home of the J.C. Ayer patent medicine company, the condo studios opened in 2000 along with a ground - level gallery that shows work by the residents and other local artists.

Dresdner Bank, Weleda AG, a large homeopathic medicine company, and 23 kindergartens in Lorrach all purchase 100 percent green power.

A traditional Chinese medicine company and a waste management group have joined the flood of firms from China aiming to list on the ASX.

ViaCyte is a privately - held, clinical - stage regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes.

SAN DIEGO and SAN FRANCISCO, December 22, 2014 — ViaCyte, Inc., a privately - held regenerative medicine company with the first stem cell - derived islet replacement therapy for the treatment of diabetes in clinical trials, today announced that Dr. Paul Laikind, President and Chief Executive Officer, will present and participate in moderated panel discussions at the upcoming Biotech Showcase ™ taking place January 12 - 15, 2015 in San Francisco.

San Diego, California, October 6, 2014 — ViaCyte, Inc., a privately - held regenerative medicine company developing a stem cell - derived islet replacement therapy for the treatment of diabetes, called VC - 01 ™, will give two presentations at the annual Stem Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as follows:

Fenwick client Omada Health, a digital behavioral medicine company that helps people change habits that put them at risk for preventable chronic conditions, raised the largest investment of the quarter for this subsector in a $ 48 million Series C financing.

Regenerative medicine company Avita Medical has raised $ 10 million from investors to support the commercialisation of its ReCell device, which is being trialled by a US government agency.

Pot - O - Coffee is an innovative Alternative Medicine company, with a focus on licensing intellectual properties for the production of THC and CBD infused products.

Tempus is a precision medicine company that uses a machine learning health care data analytics platform to enable physicians to deliver personalized care to cancer patients.

Transcriptic CEO Max Hodak says his company's services have appealed most to personalized medicine companies, such as De Silva's, and to synthetic biology companies that are tweaking the DNA of microorganisms to make them produce useful substances.

RepliCel Life Sciences Inc. (OTCQB: REPCF)(TSX.V: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today the publication of a paper out of the University of Calgary in conjunction with co-authors from Kyoto University and the University of North Carolina, which further validates the company's ongoing clinical research using dermal sheath cup (DSC) cells to reverse the effects of pattern baldness.

«This will strengthen our ability to allocate capital to grow our core businesses, drive shareholder returns, and execute value creating bolt - on acquisitions as we continue to build the leading medicines company, powered by digital and data.»

BlueRock Therapeutics is the creation of pharma giant Bayer and Versant Ventures, which set out create a next - generation regenerative - medicine company.

• Fortuna Fix, a Canada - based regenerative medicine company, raised $ 25 million in Series B funding.

RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting the skin and tendons.

Omada Health is a digital behavioral medicine company that helps people change habits that put them at risk for preventable chronic conditions.

Cynata Therapeutics Limited is an Australian clinical - stage stem cell and regenerative medicine company developing therapies based on its proprietary Cymerus ™ stem cell technology platform.

San Diego, May 22, 2017 — ViaCyte, Inc., a privately - held leading regenerative medicine company, announced today that the U.S. Food and Drug Administration (FDA) has allowed the company's Investigational New Drug Application (IND) for the PEC - Direct ™ product candidate, a novel islet cell replacement therapy in development as a potential cure for patients with type 1 diabetes who are at high risk for acute life - threatening complications.

SAN DIEGO, November 4, 2016 — ViaCyte, Inc., a privately - held regenerative medicine company, today announced two presentations at upcoming healthcare events.

SAN DIEGO and BETHESDA, MD, March 3, 2015 — ViaCyte, Inc., a privately - held regenerative medicine company with the first stem cell - derived islet replacement therapy for the treatment of diabetes in clinical trials, today announced a presentation by Dr. Eugene Brandon, Director of Strategic Relations and Project Management, at the JDRF TypeOneNation Summit.

SAN DIEGO, April 20, 2016 — ViaCyte, Inc., a privately - held regenerative medicine company with the first pluripotent stem cell - derived islet replacement therapy for the treatment of diabetes in clinical - stage development, today announced four presentations at upcoming healthcare events.

Cell Habitats US - based, pre-clinical stage, regenerative medicine company, founded in 2005.

New York and San Diego, May 22, 2017 — ViaCyte, Inc., a privately - held leading regenerative medicine company, and JDRF, the leading global organization funding type 1 diabetes research, jointly announced today JDRF grant funding to support the development of the PEC - Direct ™ islet cell replacement therapy being developed for type 1 diabetes patients with severe life - threatening hypoglycemia unawareness and related risks.

SAN DIEGO, October 4, 2017 — ViaCyte, Inc., a privately - held regenerative medicine company, today announced upcoming company presentations at the Cell and Gene Meeting on the Mesa and the BIO Investor Forum.

SAN DIEGO, April 12, 2018 — ViaCyte, Inc., a privately - held regenerative medicine company, today announced President and CEO, Paul Laikind, Ph.D., will present at Alliance for Regenerative Medicine's 6th Annual Cell & Gene Therapy Investor Day in New York.

SAN DIEGO, September 9, 2016 — ViaCyte, Inc., a privately - held regenerative medicine company with the first pluripotent stem cell - derived islet replacement therapy for the treatment of diabetes in clinical - stage development, today announced participation on a panel at the 2016 BioPharm ™ America — 9th Annual International Partnering Conference.

Understanding the current IP landscape for regenerative medicine companies — What entreprenuers, scientists, tech tranfers directors and investors need to know about protecting their IP — Identifying and overcoming licensing issues

SAN DIEGO, August 12, 2016 — ViaCyte, Inc., a privately - held regenerative medicine company with the first pluripotent stem cell - derived islet replacement therapy for the treatment of diabetes in clinical - stage development, today announced a presentation at Rejuvenation Biotechnology 2016 (RB2016).